ADENOVIRUS-MEDIATED EX-VIVO IMMUNOGENE AND IN-VIVO COMBINATION GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL
B. Bonnekoh et al., ADENOVIRUS-MEDIATED EX-VIVO IMMUNOGENE AND IN-VIVO COMBINATION GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL, Cancer gene therapy, 4(5), 1997, pp. 305-305